Artivion, Inc. (AORT)
USD 22.06
(-4.46%)
USD 22.06
(-4.46%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 300.4 Million USD | -5.38% |
| 2022 | 317.47 Million USD | 3.4% |
| 2021 | 307.03 Million USD | 20.21% |
| 2020 | 255.41 Million USD | 21.13% |
| 2019 | 210.85 Million USD | 15.82% |
| 2018 | 182.05 Million USD | -1.93% |
| 2017 | 185.63 Million USD | 1204.26% |
| 2016 | 14.23 Million USD | 132.78% |
| 2015 | -43.41 Million USD | -30.09% |
| 2014 | -33.37 Million USD | 22.37% |
| 2013 | -42.99 Million USD | -134.52% |
| 2012 | -18.33 Million USD | 15.54% |
| 2011 | -21.7 Million USD | 38.85% |
| 2010 | -35.49 Million USD | -19.09% |
| 2009 | -29.8 Million USD | -76.51% |
| 2008 | -16.88 Million USD | -71.78% |
| 2007 | -9.83 Million USD | -1927.14% |
| 2006 | 538 Thousand USD | 134.78% |
| 2005 | -1.54 Million USD | 45.98% |
| 2004 | -2.86 Million USD | 10.02% |
| 2003 | -3.18 Million USD | -107.09% |
| 2002 | -1.53 Million USD | -118.89% |
| 2001 | 8.13 Million USD | 282.14% |
| 2000 | -4.46 Million USD | -965.89% |
| 1999 | 516 Thousand USD | 109.21% |
| 1998 | -5.6 Million USD | -130.6% |
| 1997 | 18.3 Million USD | 1207.14% |
| 1996 | 1.4 Million USD | 800.0% |
| 1995 | -200 Thousand USD | 92.31% |
| 1994 | -2.6 Million USD | -85.71% |
| 1993 | -1.4 Million USD | -255.56% |
| 1992 | 900 Thousand USD | 200.0% |
| 1991 | 300 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 311.49 Million USD | 3.69% |
| 2024 Q2 | 307.61 Million USD | -1.25% |
| 2023 Q2 | 306.36 Million USD | -5.7% |
| 2023 FY | 300.4 Million USD | -5.38% |
| 2023 Q4 | 300.4 Million USD | -1.19% |
| 2023 Q3 | 304.02 Million USD | -0.77% |
| 2023 Q1 | 324.88 Million USD | 2.33% |
| 2022 Q4 | 317.47 Million USD | -0.19% |
| 2022 Q2 | 317.26 Million USD | 2.79% |
| 2022 Q3 | 318.09 Million USD | 0.26% |
| 2022 FY | 317.47 Million USD | 3.4% |
| 2022 Q1 | 308.64 Million USD | 0.52% |
| 2021 Q2 | 309.14 Million USD | 4.91% |
| 2021 Q3 | 293.63 Million USD | -5.02% |
| 2021 Q4 | 307.03 Million USD | 4.56% |
| 2021 Q1 | 294.66 Million USD | 15.37% |
| 2021 FY | 307.03 Million USD | 20.21% |
| 2020 Q4 | 255.41 Million USD | 3.22% |
| 2020 Q1 | 203.35 Million USD | -3.56% |
| 2020 Q3 | 247.44 Million USD | 33.19% |
| 2020 Q2 | 185.77 Million USD | -8.65% |
| 2020 FY | 255.41 Million USD | 21.13% |
| 2019 FY | 210.85 Million USD | 15.82% |
| 2019 Q2 | 200.18 Million USD | -0.02% |
| 2019 Q4 | 210.85 Million USD | 4.35% |
| 2019 Q3 | 202.07 Million USD | 0.95% |
| 2019 Q1 | 200.22 Million USD | 9.98% |
| 2018 Q4 | 182.05 Million USD | -0.67% |
| 2018 Q3 | 183.28 Million USD | -5.15% |
| 2018 FY | 182.05 Million USD | -1.93% |
| 2018 Q2 | 193.23 Million USD | 0.99% |
| 2018 Q1 | 191.34 Million USD | 3.08% |
| 2017 Q3 | 13.82 Million USD | -11.45% |
| 2017 Q1 | 12.35 Million USD | -13.17% |
| 2017 Q2 | 15.61 Million USD | 26.35% |
| 2017 FY | 185.63 Million USD | 1204.26% |
| 2017 Q4 | 185.63 Million USD | 1242.55% |
| 2016 FY | 14.23 Million USD | 132.78% |
| 2016 Q3 | 17.3 Million USD | -31.61% |
| 2016 Q2 | 25.3 Million USD | -8.79% |
| 2016 Q1 | 27.74 Million USD | 163.9% |
| 2016 Q4 | 14.23 Million USD | -17.76% |
| 2015 Q4 | -43.41 Million USD | -12.78% |
| 2015 FY | -43.41 Million USD | -30.09% |
| 2015 Q1 | -38.24 Million USD | -14.58% |
| 2015 Q2 | -35.07 Million USD | 8.28% |
| 2015 Q3 | -38.49 Million USD | -9.76% |
| 2014 Q2 | -36.84 Million USD | 4.17% |
| 2014 Q4 | -33.37 Million USD | -11.91% |
| 2014 FY | -33.37 Million USD | 22.37% |
| 2014 Q3 | -29.82 Million USD | 19.05% |
| 2014 Q1 | -38.44 Million USD | 10.57% |
| 2013 Q2 | -11.73 Million USD | -35.91% |
| 2013 Q3 | -23 Million USD | -96.05% |
| 2013 FY | -42.99 Million USD | -134.52% |
| 2013 Q4 | -42.99 Million USD | -86.93% |
| 2013 Q1 | -8.63 Million USD | 52.91% |
| 2012 Q1 | -21.14 Million USD | 2.58% |
| 2012 Q4 | -18.33 Million USD | -135.33% |
| 2012 Q2 | -3.99 Million USD | 81.09% |
| 2012 Q3 | -7.79 Million USD | -94.8% |
| 2012 FY | -18.33 Million USD | 15.54% |
| 2011 Q3 | -21.05 Million USD | -6.31% |
| 2011 FY | -21.7 Million USD | 38.85% |
| 2011 Q4 | -21.7 Million USD | -3.11% |
| 2011 Q2 | -19.8 Million USD | 47.31% |
| 2011 Q1 | -37.58 Million USD | -5.87% |
| 2010 FY | -35.49 Million USD | -19.09% |
| 2010 Q1 | -30.59 Million USD | -2.64% |
| 2010 Q2 | -35.35 Million USD | -15.56% |
| 2010 Q4 | -35.49 Million USD | -16.01% |
| 2010 Q3 | -30.59 Million USD | 13.45% |
| 2009 Q1 | -17.86 Million USD | -5.81% |
| 2009 Q4 | -29.8 Million USD | -11.5% |
| 2009 Q3 | -26.73 Million USD | -28.39% |
| 2009 Q2 | -20.82 Million USD | -16.53% |
| 2009 FY | -29.8 Million USD | -76.51% |
| 2008 Q1 | -11.93 Million USD | -21.4% |
| 2008 Q4 | -16.88 Million USD | -19.77% |
| 2008 FY | -16.88 Million USD | -71.78% |
| 2008 Q3 | -14.09 Million USD | -35.66% |
| 2008 Q2 | -10.39 Million USD | 12.91% |
| 2007 Q4 | -9.83 Million USD | -235.61% |
| 2007 FY | -9.83 Million USD | -1927.14% |
| 2007 Q1 | -908 Thousand USD | -268.77% |
| 2007 Q2 | 451 Thousand USD | 149.67% |
| 2007 Q3 | -2.92 Million USD | -749.45% |
| 2006 Q1 | 172 Thousand USD | 111.12% |
| 2006 FY | 538 Thousand USD | 134.78% |
| 2006 Q4 | 538 Thousand USD | -50.69% |
| 2006 Q3 | 1.09 Million USD | -48.27% |
| 2006 Q2 | 2.1 Million USD | 1126.16% |
| 2005 Q3 | -2.96 Million USD | -197.29% |
| 2005 Q2 | -997 Thousand USD | 95.19% |
| 2005 Q1 | -20.74 Million USD | -624.37% |
| 2005 FY | -1.54 Million USD | 45.98% |
| 2005 Q4 | -1.54 Million USD | 47.81% |
| 2004 FY | -2.86 Million USD | 10.02% |
| 2004 Q3 | -8.19 Million USD | 46.91% |
| 2004 Q2 | -15.43 Million USD | 22.17% |
| 2004 Q4 | -2.86 Million USD | 65.05% |
| 2004 Q1 | -19.83 Million USD | -523.0% |
| 2003 Q1 | 1.28 Million USD | 183.47% |
| 2003 FY | -3.18 Million USD | -107.09% |
| 2003 Q4 | -3.18 Million USD | 32.61% |
| 2003 Q3 | -4.72 Million USD | 31.66% |
| 2003 Q2 | -6.91 Million USD | -638.66% |
| 2002 Q2 | -2.44 Million USD | -163.67% |
| 2002 Q1 | 3.83 Million USD | -52.89% |
| 2002 Q3 | -2.93 Million USD | -20.11% |
| 2002 FY | -1.53 Million USD | -118.89% |
| 2002 Q4 | -1.53 Million USD | 47.58% |
| 2001 Q4 | 8.13 Million USD | 235.17% |
| 2001 Q2 | -2.83 Million USD | -4.85% |
| 2001 Q3 | 2.42 Million USD | 185.8% |
| 2001 Q1 | -2.69 Million USD | 39.59% |
| 2001 FY | 8.13 Million USD | 282.14% |
| 2000 Q3 | -2.76 Million USD | -79.29% |
| 2000 Q1 | 633 Thousand USD | 22.67% |
| 2000 FY | -4.46 Million USD | -965.89% |
| 2000 Q4 | -4.46 Million USD | -61.83% |
| 2000 Q2 | -1.54 Million USD | -343.29% |
| 1999 Q4 | 516 Thousand USD | -60.31% |
| 1999 Q2 | 1.9 Million USD | 733.33% |
| 1999 Q1 | -300 Thousand USD | 94.64% |
| 1999 FY | 516 Thousand USD | 109.21% |
| 1999 Q3 | 1.3 Million USD | -31.58% |
| 1998 Q3 | -38.9 Million USD | -54.37% |
| 1998 Q2 | -25.2 Million USD | -220.57% |
| 1998 FY | -5.6 Million USD | -130.6% |
| 1998 Q1 | 20.9 Million USD | 14.21% |
| 1998 Q4 | -5.6 Million USD | 85.6% |
| 1997 Q2 | 15.7 Million USD | 6.08% |
| 1997 Q3 | 16.8 Million USD | 7.01% |
| 1997 Q4 | 18.3 Million USD | 8.93% |
| 1997 Q1 | 14.8 Million USD | 957.14% |
| 1997 FY | 18.3 Million USD | 1207.14% |
| 1996 Q4 | 1.4 Million USD | 250.0% |
| 1996 Q1 | -1.3 Million USD | -550.0% |
| 1996 FY | 1.4 Million USD | 800.0% |
| 1996 Q2 | 100 Thousand USD | 107.69% |
| 1996 Q3 | 400 Thousand USD | 300.0% |
| 1995 Q3 | -1.1 Million USD | 35.29% |
| 1995 Q4 | -200 Thousand USD | 81.82% |
| 1995 Q2 | -1.7 Million USD | -41.67% |
| 1995 FY | -200 Thousand USD | 92.31% |
| 1995 Q1 | -1.2 Million USD | 53.85% |
| 1994 Q2 | -600 Thousand USD | -50.0% |
| 1994 Q3 | -1.4 Million USD | -133.33% |
| 1994 Q4 | -2.6 Million USD | -85.71% |
| 1994 FY | -2.6 Million USD | -85.71% |
| 1994 Q1 | -400 Thousand USD | 71.43% |
| 1993 Q2 | -3.7 Million USD | 0.0% |
| 1993 FY | -1.4 Million USD | -255.56% |
| 1993 Q4 | -1.4 Million USD | 26.32% |
| 1993 Q3 | -1.9 Million USD | 48.65% |
| 1992 FY | 900 Thousand USD | 200.0% |
| 1992 Q4 | 900 Thousand USD | 0.0% |
| 1991 FY | 300 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott Laboratories | 8.97 Billion USD | 96.654% |
| Allurion Technologies Inc. | 3.82 Million USD | -7763.901% |
| Avanos Medical, Inc. | 121.4 Million USD | -147.447% |
| Butterfly Network, Inc. | -109.6 Million USD | 374.066% |
| Butterfly Network, Inc. | -109.6 Million USD | 374.066% |
| Bio-Rad Laboratories, Inc. | 1 Billion USD | 70.018% |
| Boston Scientific Corporation | 8.62 Billion USD | 96.518% |
| CONMED Corporation | 966.95 Million USD | 68.933% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 166.89% |
| Paragon 28, Inc. | 36.39 Million USD | -725.482% |
| Glaukos Corporation | 290.27 Million USD | -3.49% |
| Globus Medical, Inc. | 53.11 Million USD | -465.599% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 286.943% |
| Integer Holdings Corporation | 1.01 Billion USD | 70.47% |
| Medtronic plc | 24.76 Billion USD | 98.787% |
| Myomo, Inc. | -6.27 Million USD | 4891.082% |
| Nevro Corp. | 117.61 Million USD | -155.421% |
| Owlet, Inc. | -1.34 Million USD | 22501.284% |
| Penumbra, Inc. | 66.85 Million USD | -349.319% |
| Vicarious Surgical Inc. | -37.99 Million USD | 890.737% |
| Smith & Nephew plc | 2.78 Billion USD | 89.202% |
| Sonendo, Inc. | 26.34 Million USD | -1040.388% |
| STERIS plc | 3.17 Billion USD | 90.542% |
| Stryker Corporation | 10.02 Billion USD | 97.003% |
| Vapotherm, Inc. | 102.66 Million USD | -192.597% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 94.616% |